OncoSpherix is pleased to announce that Dr. Harvey Golomb has joined the Clinical Advisory Board of OncoSpherix. Dr. Golomb’s recognition as a preeminent leader in oncology began early in his career, as reflected by his election in 1990 as President of the American Society of Clinical Oncology, the world’s largest organization representing physicians and oncology professionals of all oncology sub-specialties. He is a prolific researcher and thought-leader in clinical oncology, as seen by his authorship of more than 350 peer reviewed articles and co-editing of multiple editions of Oncologic Therapies, an industry textbook. Most of his professional career has been at the University of Chicago Medical Center where he served as section head of the Division of Hematology and Oncology, followed by Chairman of the Department of Medicine and then Dean of Clinical Affairs and Chief Medical Officer. “We are honored that Dr. Golomb will be serving as an advisor to OncoSpherix as we transition towards a clinical stage company focused on advanced cancer,” stated OncoSpherix’s CEO, Dr. Margaret K. Offermann. “Dr. Golomb has always been an outstanding mentor and friend that began when I was a resident at the University of Chicago. I’m honored that he is serving as a clinical advisor to OncoSpherix as we make important decisions on our clinical development priorities and strategy.”
